The Experts below are selected from a list of 306 Experts worldwide ranked by ideXlab platform
Martin A Weinstock - One of the best experts on this subject based on the ideXlab platform.
-
a risk adjustment approach to estimating the burden of Skin Disease in the united states
Journal of The American Academy of Dermatology, 2018Co-Authors: Henry W Lim, Scott A B Collins, Jack S Resneck, Jean L Bolognia, Julie A Hodge, Thomas A Rohrer, Marta J Van Beek, David J Margolis, Arthur J Sober, Martin A WeinstockAbstract:Direct insurance claims tabulation and risk adjustment statistical methods can be used to estimate health care costs associated with various Diseases. In this third manuscript derived from the new national Burden of Skin Disease Report from the American Academy of Dermatology, a risk adjustment method that was based on modeling the average annual costs of individuals with or without specific Diseases, and specifically tailored for 24 Skin Disease categories, was used to estimate the economic burden of Skin Disease. The results were compared with the claims tabulation method used in the first 2 parts of this project. The risk adjustment method estimated the direct health care costs of Skin Diseases to be $46 billion in 2013, approximately $15 billion less than estimates using claims tabulation. For individual Skin Diseases, the risk adjustment cost estimates ranged from 11% to 297% of those obtained using claims tabulation for the 10 most costly Skin Disease categories. Although either method may be used for purposes of estimating the costs of Skin Disease, the choice of method will affect the end result. These findings serve as an important reference for future discussions about the method chosen in health care payment models to estimate both the cost of Skin Disease and the potential cost impact of care changes.
-
contribution of health care factors to the burden of Skin Disease in the united states
Journal of The American Academy of Dermatology, 2017Co-Authors: Henry W Lim, Scott A B Collins, Jack S Resneck, Jean L Bolognia, Julie A Hodge, Thomas A Rohrer, Marta J Van Beek, David J Margolis, Arthur J Sober, Martin A WeinstockAbstract:The American Academy of Dermatology has developed an up-to-date national Burden of Skin Disease Report on the impact of Skin Disease on patients and on the US population. In this second of 3 manuscripts, data are presented on specific health care dimensions that contribute to the overall burden of Skin Disease. Through the use of data derived from medical claims in 2013 for 24 Skin Disease categories, these results indicate that Skin Disease health care is delivered most frequently to the aging US population, who are afflicted with more Skin Diseases than other age groups. Furthermore, the overall cost of Skin Disease is highest within the commercially insured population, and Skin Disease treatment primarily occurs in the outpatient setting. Dermatologists provided approximately 30% of office visit care and performed nearly 50% of cutaneous surgeries. These findings serve as a critical foundation for future discussions on the clinical importance of Skin Disease and the value of dermatologic care across the population.
-
the burden of Skin Disease in the united states
Journal of The American Academy of Dermatology, 2017Co-Authors: Henry W Lim, Scott A B Collins, Jack S Resneck, Jean L Bolognia, Julie A Hodge, Thomas A Rohrer, Marta J Van Beek, David J Margolis, Arthur J Sober, Martin A WeinstockAbstract:Since the publication of the last US national burden of Skin Disease report in 2006, there have been substantial changes in the practice of dermatology and the US health care system. These include the development of new treatment modalities, marked increases in the cost of medications, increasingly complex payer rules and regulations, and an aging of the US population. Recognizing the need for up-to-date data to inform researchers, policy makers, public stakeholders, and health care providers about the impact of Skin Disease on patients and US society, the American Academy of Dermatology produced a new national burden of Skin Disease report. Using 2013 claims data from private and governmental insurance providers, this report analyzed the prevalence, cost, and mortality attributable to 24 Skin Disease categories in the US population. In this first of 3 articles, the presented data demonstrate that nearly 85 million Americans were seen by a physician for at least 1 Skin Disease in 2013. This led to an estimated direct health care cost of $75 billion and an indirect lost opportunity cost of $11 billion. Further, mortality was noted in half of the 24 Skin Disease categories.
Henry W Lim - One of the best experts on this subject based on the ideXlab platform.
-
a risk adjustment approach to estimating the burden of Skin Disease in the united states
Journal of The American Academy of Dermatology, 2018Co-Authors: Henry W Lim, Scott A B Collins, Jack S Resneck, Jean L Bolognia, Julie A Hodge, Thomas A Rohrer, Marta J Van Beek, David J Margolis, Arthur J Sober, Martin A WeinstockAbstract:Direct insurance claims tabulation and risk adjustment statistical methods can be used to estimate health care costs associated with various Diseases. In this third manuscript derived from the new national Burden of Skin Disease Report from the American Academy of Dermatology, a risk adjustment method that was based on modeling the average annual costs of individuals with or without specific Diseases, and specifically tailored for 24 Skin Disease categories, was used to estimate the economic burden of Skin Disease. The results were compared with the claims tabulation method used in the first 2 parts of this project. The risk adjustment method estimated the direct health care costs of Skin Diseases to be $46 billion in 2013, approximately $15 billion less than estimates using claims tabulation. For individual Skin Diseases, the risk adjustment cost estimates ranged from 11% to 297% of those obtained using claims tabulation for the 10 most costly Skin Disease categories. Although either method may be used for purposes of estimating the costs of Skin Disease, the choice of method will affect the end result. These findings serve as an important reference for future discussions about the method chosen in health care payment models to estimate both the cost of Skin Disease and the potential cost impact of care changes.
-
contribution of health care factors to the burden of Skin Disease in the united states
Journal of The American Academy of Dermatology, 2017Co-Authors: Henry W Lim, Scott A B Collins, Jack S Resneck, Jean L Bolognia, Julie A Hodge, Thomas A Rohrer, Marta J Van Beek, David J Margolis, Arthur J Sober, Martin A WeinstockAbstract:The American Academy of Dermatology has developed an up-to-date national Burden of Skin Disease Report on the impact of Skin Disease on patients and on the US population. In this second of 3 manuscripts, data are presented on specific health care dimensions that contribute to the overall burden of Skin Disease. Through the use of data derived from medical claims in 2013 for 24 Skin Disease categories, these results indicate that Skin Disease health care is delivered most frequently to the aging US population, who are afflicted with more Skin Diseases than other age groups. Furthermore, the overall cost of Skin Disease is highest within the commercially insured population, and Skin Disease treatment primarily occurs in the outpatient setting. Dermatologists provided approximately 30% of office visit care and performed nearly 50% of cutaneous surgeries. These findings serve as a critical foundation for future discussions on the clinical importance of Skin Disease and the value of dermatologic care across the population.
-
the burden of Skin Disease in the united states
Journal of The American Academy of Dermatology, 2017Co-Authors: Henry W Lim, Scott A B Collins, Jack S Resneck, Jean L Bolognia, Julie A Hodge, Thomas A Rohrer, Marta J Van Beek, David J Margolis, Arthur J Sober, Martin A WeinstockAbstract:Since the publication of the last US national burden of Skin Disease report in 2006, there have been substantial changes in the practice of dermatology and the US health care system. These include the development of new treatment modalities, marked increases in the cost of medications, increasingly complex payer rules and regulations, and an aging of the US population. Recognizing the need for up-to-date data to inform researchers, policy makers, public stakeholders, and health care providers about the impact of Skin Disease on patients and US society, the American Academy of Dermatology produced a new national burden of Skin Disease report. Using 2013 claims data from private and governmental insurance providers, this report analyzed the prevalence, cost, and mortality attributable to 24 Skin Disease categories in the US population. In this first of 3 articles, the presented data demonstrate that nearly 85 million Americans were seen by a physician for at least 1 Skin Disease in 2013. This led to an estimated direct health care cost of $75 billion and an indirect lost opportunity cost of $11 billion. Further, mortality was noted in half of the 24 Skin Disease categories.
M. Mayxay - One of the best experts on this subject based on the ideXlab platform.
-
Assessing Skin Disease and associated health-related quality of life in a rural Lao community
BMC Dermatology, 2018Co-Authors: C. I. Wootton, S. Bell, A. Philavanh, K. Phommachack, M. Soukavong, S. Kidoikhammouan, S. L. Walker, M. MayxayAbstract:Background Skin Diseases are common and often have an impact on an individual’s health-related quality of life. In rural communities where access to healthcare may be limited and individuals rely on farming for food and income, the impact of Skin Diseases may be greater. The objectives for this study were to perform an assessment of Skin Disease prevalence in a rural village in Laos and assess the associated impact of any Skin Disease found using the Dermatology Life Quality Index (DLQI). Methods A rural village was purposively selected and 340 participants examined by dermatologists over a four day period. Brief questionnaires were performed, followed by full body Skin examinations and DLQI questionnaires completed were relevant. The data were analysed using chi square and Wilcoxon signed rank tests. Results One hundred and eighty-one participants were found to have a Skin Disease (53%). The six most common Skin Diseases were: eczema (22%), dermatophyte infections (19%), acne (10%), scabies infestation (9%), melasma (8%) and pityriasis versicolor (4%). Just over half of those with Skin Disease (51%) completed the DLQI, with scores ranging from 0 to 24. Those with Skin problems on examination were significantly more likely to be farmers, have had a previous Skin problem, be older or live in a smaller family. Conclusions This study represents the first formal documentation of Skin Disease prevalence in Laos and establishes the high rate of Skin Disease in the rural community and the associated impact these Diseases have on health-related quality of life.
Thierry Lefrançois - One of the best experts on this subject based on the ideXlab platform.
-
Spread rate of lumpy Skin Disease in the Balkans, 2015-2016.
Transboundary and emerging diseases, 2017Co-Authors: Alize Mercier, Elena Arsevska, Laure Bournez, Anne-christine Bronner, Didier Calavas, Julien Cauchard, Sylvain Falala, Philippe Caufour, Clément Tisseuil, Thierry LefrançoisAbstract:After its introduction in Turkey in November 2013 and subsequent spread in this country, lumpy Skin Disease (LSD) was first reported in the western Turkey in May 2015. It was observed in cattle in Greece and reported to the World Organization for Animal Health (OIE) in August 2015. From May 2015 to August 2016, 1,092 outbreaks of lumpy Skin Disease were reported in cattle from western Turkey and eight Balkan countries: Greece, Bulgaria, The Former Yugoslav Republic of Macedonia, Serbia, Kosovo, and Albania. During this period, the median LSD spread rate was 7.3 km/week. The frequency of outbreaks was highly seasonal, with little or no transmission reported during the winter. Also, the skewed distribution of spread rates suggested two distinct underlying epidemiological processes, associating local and distant spread possibly related to vectors and cattle trade movements, respectively. (Resume d'auteur)
David J Margolis - One of the best experts on this subject based on the ideXlab platform.
-
a risk adjustment approach to estimating the burden of Skin Disease in the united states
Journal of The American Academy of Dermatology, 2018Co-Authors: Henry W Lim, Scott A B Collins, Jack S Resneck, Jean L Bolognia, Julie A Hodge, Thomas A Rohrer, Marta J Van Beek, David J Margolis, Arthur J Sober, Martin A WeinstockAbstract:Direct insurance claims tabulation and risk adjustment statistical methods can be used to estimate health care costs associated with various Diseases. In this third manuscript derived from the new national Burden of Skin Disease Report from the American Academy of Dermatology, a risk adjustment method that was based on modeling the average annual costs of individuals with or without specific Diseases, and specifically tailored for 24 Skin Disease categories, was used to estimate the economic burden of Skin Disease. The results were compared with the claims tabulation method used in the first 2 parts of this project. The risk adjustment method estimated the direct health care costs of Skin Diseases to be $46 billion in 2013, approximately $15 billion less than estimates using claims tabulation. For individual Skin Diseases, the risk adjustment cost estimates ranged from 11% to 297% of those obtained using claims tabulation for the 10 most costly Skin Disease categories. Although either method may be used for purposes of estimating the costs of Skin Disease, the choice of method will affect the end result. These findings serve as an important reference for future discussions about the method chosen in health care payment models to estimate both the cost of Skin Disease and the potential cost impact of care changes.
-
contribution of health care factors to the burden of Skin Disease in the united states
Journal of The American Academy of Dermatology, 2017Co-Authors: Henry W Lim, Scott A B Collins, Jack S Resneck, Jean L Bolognia, Julie A Hodge, Thomas A Rohrer, Marta J Van Beek, David J Margolis, Arthur J Sober, Martin A WeinstockAbstract:The American Academy of Dermatology has developed an up-to-date national Burden of Skin Disease Report on the impact of Skin Disease on patients and on the US population. In this second of 3 manuscripts, data are presented on specific health care dimensions that contribute to the overall burden of Skin Disease. Through the use of data derived from medical claims in 2013 for 24 Skin Disease categories, these results indicate that Skin Disease health care is delivered most frequently to the aging US population, who are afflicted with more Skin Diseases than other age groups. Furthermore, the overall cost of Skin Disease is highest within the commercially insured population, and Skin Disease treatment primarily occurs in the outpatient setting. Dermatologists provided approximately 30% of office visit care and performed nearly 50% of cutaneous surgeries. These findings serve as a critical foundation for future discussions on the clinical importance of Skin Disease and the value of dermatologic care across the population.
-
the burden of Skin Disease in the united states
Journal of The American Academy of Dermatology, 2017Co-Authors: Henry W Lim, Scott A B Collins, Jack S Resneck, Jean L Bolognia, Julie A Hodge, Thomas A Rohrer, Marta J Van Beek, David J Margolis, Arthur J Sober, Martin A WeinstockAbstract:Since the publication of the last US national burden of Skin Disease report in 2006, there have been substantial changes in the practice of dermatology and the US health care system. These include the development of new treatment modalities, marked increases in the cost of medications, increasingly complex payer rules and regulations, and an aging of the US population. Recognizing the need for up-to-date data to inform researchers, policy makers, public stakeholders, and health care providers about the impact of Skin Disease on patients and US society, the American Academy of Dermatology produced a new national burden of Skin Disease report. Using 2013 claims data from private and governmental insurance providers, this report analyzed the prevalence, cost, and mortality attributable to 24 Skin Disease categories in the US population. In this first of 3 articles, the presented data demonstrate that nearly 85 million Americans were seen by a physician for at least 1 Skin Disease in 2013. This led to an estimated direct health care cost of $75 billion and an indirect lost opportunity cost of $11 billion. Further, mortality was noted in half of the 24 Skin Disease categories.
